Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Examining Oncolytic Poliovirus Bioactivity in Tumor Tissue After Intratumoral Administration of PVSRIPO in Women With Invasive Breast Cancer

NCT03564782 is registered in ClinicalTrials.gov with Istari Oncology, Inc. as lead sponsor.

NCT NCT03564782
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03564782 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Examining Oncolytic Poliovirus Bioactivity in Tumor Tissue After Intratumoral Administration of PVSRIPO in Women With Invasive Breast Cancer
Lead sponsor
Istari Oncology, Inc.
Phase
Phase 1
Overall status
Completed
Start date
June 30, 2019
Completion date
April 11, 2022
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

invasive breast cancer